home / stock / aktx / aktx short
Short Information | Akari Therapeutics Plc (NASDAQ:AKTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 65,770 |
Total Actual Volume | 499,586 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 3,289 |
Average Short Percentage | 14.44% |
Is there a AKTX Short Squeeze or Breakout about to happen?
See the AKTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $3.62 | $3.53 | $3.87 | $3.53 | 3,092 | 1,369 | 44.28% |
07-18-2024 | $3.88 | $3.64 | $3.91 | $3.63 | 21,566 | 9,925 | 46.02% |
07-17-2024 | $3.85 | $3.83 | $3.85 | $3.755 | 18,469 | 1,974 | 10.69% |
07-16-2024 | $3.66 | $3.7001 | $3.86 | $3.51 | 34,959 | 7,717 | 22.07% |
07-15-2024 | $3.5 | $3.74 | $3.74 | $3.5 | 16,726 | 1,401 | 8.38% |
07-12-2024 | $3.56 | $3.5 | $3.6402 | $3.29 | 26,460 | 4,438 | 16.77% |
07-11-2024 | $3.49 | $3.5307 | $3.729 | $3.3801 | 48,033 | 3,530 | 7.35% |
07-10-2024 | $2.98 | $3.38 | $3.53 | $2.8701 | 42,718 | 8,586 | 20.1% |
07-09-2024 | $2.84 | $2.81 | $2.98 | $2.68 | 8,630 | 106 | 1.23% |
07-08-2024 | $2.84 | $2.88 | $3.03 | $2.84 | 5,717 | 416 | 7.28% |
07-05-2024 | $3.18 | $2.87 | $3.18 | $2.8292 | 8,706 | 1,574 | 18.08% |
07-03-2024 | $3.23 | $3.1818 | $3.3066 | $3.1008 | 2,374 | 102 | 4.3% |
07-02-2024 | $3.27 | $3.1 | $3.4 | $3.0401 | 23,783 | 2,138 | 8.99% |
07-01-2024 | $2.85 | $3.215 | $3.63 | $2.85 | 26,381 | 3,800 | 14.4% |
06-28-2024 | $2.7 | $2.7 | $2.7 | $2.61 | 12,396 | 1,048 | 8.45% |
06-27-2024 | $2.66 | $2.63 | $3.11 | $2.62 | 17,980 | 1,093 | 6.08% |
06-26-2024 | $2.89 | $2.72 | $3.1079 | $2.71 | 20,340 | 2,115 | 10.4% |
06-25-2024 | $3.6 | $2.77 | $3.64 | $2.73 | 70,963 | 5,501 | 7.75% |
06-24-2024 | $3.8 | $3.66 | $3.89 | $3.4914 | 23,288 | 4,600 | 19.75% |
06-21-2024 | $3.05 | $3.71 | $3.9399 | $3.05 | 67,005 | 4,337 | 6.47% |
News, Short Squeeze, Breakout and More Instantly...
Akari Therapeutics Plc Company Name:
AKTX Stock Symbol:
NASDAQ Market:
Akari Therapeutics Plc Website:
Interim CEO employment contract consists solely of equity compensation Samir R. Patel, M.D., increases ownership to 14.2% with $1.25m investment in recent private placement BOSTON and LONDON, June 05, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotec...
BOSTON and LONDON, June 04, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory diseases, today announced the successful initial closing of a private placement financing round. This transaction is ...
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer Therapeutic Platform Technology and Akari’s PAS-nomacopan fo...